Expert guidance and support ensures the seamless transition to an ASX-listed entity for 1stGroup
Harnessing advanced IPO technologies to deliver real time IPO intelligence for Spheria
Leveraging EFT payment capabilities to help Noxopharm successfully list on the ASX
A full-service support model sees an increase in Zip’s market capitalisation from approximately $20M at IPO to in excess of $250M